Omega-3 Pet Supplement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The omega-3 pet supplement market size is projected to expand from USD 1.43 billion in 2025 and USD 1.58 billion in 2026 to USD 2.56 billion by 2031, registering a CAGR of 10.10% between 2026 and 2031. This report is Segmented by Pet Type (Dogs, Cats, and Other Pets), by Product Form (Soft Chews, Liquid, and More), by Source (Fish Oil, Algal Oil, and More), by Application (Skin and Coat Health, Joint and Bone Health, and More), by Distribution Channel (Veterinary Clinics and More), and by Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Omega-3 Pet Supplement Market Trends and Insights

Human-grade ingredient demand in pet nutrition

Pet owners increasingly expect pet supplements to adhere to the same manufacturing and safety standards as human food. The Association of American Feed Control Officials (AAFCO) specifies that products labeled as human grade must be manufactured, packed, and stored in compliance with regulations applicable to human edible foods. These standards enhance quality control, ingredient traceability, and manufacturing practices across the industry, enabling premium brands to differentiate their products and build consumer trust in fortified pet nutrition offerings. Manufacturers without these certifications are exiting or consolidating, as demonstrated by several contract manufacturing deals disclosed in 2025. Nordic Naturals extended its human omega-3 line to pets in 2025 and reached 10% share by highlighting identical sourcing and testing. Retailers are increasingly favoring pet supplement brands that carry the National Animal Supplement Council (NASC) Quality Seal, as it signifies adherence to established quality and safety standards while enhancing premium product positioning.

Clinical validation of Eicosapentaenoic Acid (EPA)/Docosahexaenoic Acid (DHA) for joint and cognitive health

A 2025 systematic review established specific dosing ranges for EPA and DHA in dermatology, osteoarthritis, cardiology, and cognition, transitioning from anecdotal use to evidence-based protocols. This clarity has increased veterinarian confidence and encouraged clinic recommendations, accounting for 28% of 2025 channel sales. The European Pet Food Industry Federation (FEDIAF) included minimum levels of EPA and DHA in its 2025 nutrient guidelines, emphasizing their significance in companion animal nutrition. Additionally, veterinary colleges are integrating omega-3 modules into nutrition curricula, expanding the future prescribing base. With the growing body of peer-reviewed data, product labels now frequently specify precise per-kilogram dosing to align with clinically supported ranges.

Marine-Oil Price Volatility

Peru cut its 2026 anchovy quota by 36%, squeezing global fish oil availability and lifting refined concentrate prices to USD 3,800 per metric ton. Rabobank projected a 20,000 metric ton deficit in the same year as aquaculture demand surged. Manufacturers either stockpile inventory, accept margin erosion, or raise prices, risking a shift by consumers to cheaper plant blends that provide limited Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA). Volatility complicates long-term contracts and investor forecasts. Accelerated algae commercialization offers a hedge but remains constrained by capacity today.

Other drivers and restraints analyzed in the detailed report include:

• Veterinary-led Preventive Care Programs
• Algae-Derived Omega-3 Scalability Lowering Cost Curve
• Oxidative Stability and Shelf-Life Limits

Segment Analysis

In 2025, dogs accounted for 55% of the omega-3 pet supplement market share, reflecting higher spend per animal and established veterinary joint-care protocols. Clinical evidence positions the Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) as adjuncts in the management of osteoarthritis in large breeds, supporting dog owners' willingness to pay. Nutravet’s April 2025 Nutramega launch targets this demographic with an EPA-rich formula for mobility and dermatology. Cats are projected to expand at 11.3% CAGR through 2026-2031 as awareness of feline cognitive dysfunction syndrome rises. Capsule formats that owners puncture over wet food are gaining traction, easing historical palatability barriers.

Veterinarians possess decades of canine dosage data, fostering confident prescriptions that drive clinic sales. Feline research, while limited, is growing as universities run cognition studies funded by ingredient suppliers. Younger cat owners rely on social media advice, helping direct-to-consumer brands bypass clinic endorsement. Other pets, including horses and birds, form a niche that prizes omega-3 for joint comfort and feather quality, but volumes remain modest. Future growth hinges on labeling that specifies species-appropriate dosages and flavor masking that respects feline taste sensitivity.

Soft chews accounted for 38% of sales in 2025, turning supplements into treat experiences that eliminate dosing battles. Zesty Paws doubled social media investment in 2025, using influencer content to normalize daily soft-chew routines. However, chew format limits fatty acid loading, prompting owners of large dogs to administer multiple pieces. Capsules will grow at a 10.6% CAGR, driven by microencapsulation, which enhances stability, and by algae oils, which enable smaller pill sizes. DSM-Firmenich’s Life’s Docosahexaenoic Acid (DHA) B54-0100, released in October 2024, extended shelf life beyond 24 months in sealed blister packs.

Liquids remain favored in clinics for precise titration, but oxidation risk and messy application hinder retail growth. Powders sprinkled on food serve multi-pet households looking for cost savings, although inconsistent mixing limits efficacy. Format preference often aligns with pet size. Small dogs and cats tend to prefer capsules and chews, while owners of giant breeds prefer liquids. As brands roll out multi-functional chews that combine omega-3 with probiotics or glucosamine, category boundaries blur. Certification by the National Animal Supplement Council is becoming mandatory across every format tier.

Complete Report Scope:

• By Pet Type
  • Dogs
  • Cats
  • Other Pets
• By Product Form
  • Soft Chews
  • Liquid
  • Capsules
  • Powders
• By Source
  • Fish Oil
  • Algal Oil
  • Krill Oil
  • Flaxseed
• By Application
  • Skin and Coat Health
  • Joint and Bone Health
  • Cognitive and Vision Support
  • Cardiovascular and Renal Support
  • General Wellness
• By Distribution Channel
  • Veterinary Clinics
  • Pet Specialty Stores
  • Supermarkets and Hypermarkets
  • Online Retailers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Middle East
  • Africa
    • South Africa
    • Nigeria
    • Rest of Africa

Geography Analysis

North America remains the largest regional contributor, capturing 38.5% of global revenue in 2025. High veterinary visit frequency, widespread pet insurance reimbursement, and mature e-commerce infrastructure sustain its momentum. Asia-Pacific is the fastest region, projected to advance at a 10.7% CAGR over 2026-2031 as rising middle-class incomes and urbanization lift premium pet spending. Growing regulatory clarity and an expanding veterinary workforce further anchor long-term demand in both regions.

Europe follows with steady growth, driven by a strong veterinary culture and recent nutrient guidelines that standardize minimum levels of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) set by European Pet Food Industry Federation (FEDIAF). South America benefits from rapid urbanization and improving retail access, though price sensitivity tempers premium adoption. The Middle East and Africa are building momentum as distributors introduce shelf-stable soft-chew formats suited to hot climates. Each of these regions is diversifying supply sources, including algae-derived oils, to hedge marine price swings.

Across all regions, subscription e-commerce and veterinary wellness plans are deepening repeat purchase behavior. Ingredient suppliers are localizing fermentation plants, reducing transit times, and improving freshness, thereby boosting regional competitiveness. Regulatory bodies continue to harmonize labeling standards, reducing compliance hurdles for multinational brands. These converging factors suggest that every territory will widen its contribution to global revenue through 2031, reinforcing robust overall market expansion.

List of Companies Covered in this Report:

• Nutramax Laboratories
• Nordic Naturals
• Zesty Paws LLC
• Grizzly Pet Products, LLC
• VetriScience Laboratories
• DSM-Firmenich
• BASF SE
• Aker BioMarine ASA
• Swedencare AB
• Dechra Pharmaceuticals PLC
• Hill's Pet Nutrition, Inc.
• Mars Petcare US, Inc.
• NOW Foods
• Virbac SA
• Nestlé Purina PetCare Company

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support